Kid Castle Educational Past Earnings Performance
Past criteria checks 0/6
Kid Castle Educational has been growing earnings at an average annual rate of 32.3%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 33.4% per year.
Key information
32.3%
Earnings growth rate
37.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 33.4% |
| Return on equity | -17.2% |
| Net Margin | -36.8% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Kid Castle Educational makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 2 | -1 | 2 | 0 |
| 30 Jun 23 | 3 | 0 | 2 | 0 |
| 31 Mar 23 | 3 | 0 | 2 | 0 |
| 31 Dec 22 | 4 | 1 | 2 | 0 |
| 30 Sep 22 | 5 | 3 | 0 | 0 |
| 30 Jun 22 | 6 | 3 | 0 | 0 |
| 31 Mar 22 | 8 | 2 | 0 | 0 |
| 31 Dec 21 | 7 | 2 | 0 | 0 |
| 30 Sep 21 | 6 | 1 | 0 | 0 |
| 30 Jun 21 | 5 | 1 | 0 | 0 |
| 31 Mar 21 | 2 | 0 | 0 | 0 |
| 31 Dec 20 | 1 | 0 | 0 | 0 |
| 30 Sep 20 | 1 | 0 | 0 | 0 |
| 30 Jun 20 | 0 | 0 | 0 | 0 |
| 31 Mar 20 | 0 | 0 | 0 | 0 |
| 31 Dec 19 | 0 | 0 | 0 | 0 |
Quality Earnings: KDCE is currently unprofitable.
Growing Profit Margin: KDCE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KDCE is unprofitable, but has reduced losses over the past 5 years at a rate of 32.3% per year.
Accelerating Growth: Unable to compare KDCE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: KDCE is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-15.2%).
Return on Equity
High ROE: KDCE has a negative Return on Equity (-17.23%), as it is currently unprofitable.